top of page
1186-Platelet forming megakaryocyte - 1.

PSAILA LAB

Normal and Malignant Megakaryocyte Biology

Using bone marrow organoids to model normal and malignant haematopoiesis

Myeloproliferative Neoplasms

Platelets in early detection and molecular profiling of solid tumours

Home: Welcome

RESEARCH THEMES

Learn more about our main research themes and applications below.

HOW MEGAKARYOCYTE CELLS DEVELOP FROM HAEMATOPOIETIC STEM CELLS

Studying how megakaryocytes develop and function in healthy people, and how this goes wrong in a certain type of blood cancer called ‘myeloproliferative neoplasms’ or ‘MPNs’.

Screenshot 2022-04-27 at 21.39.08.png

HUMAN BONE MARROW ORGANOIDS

Development and validation of iPSC-derived bone marrow organoids that faithfully recapitulate the cellular, molecular and architectural features of native bone marrow for disease modelling, target discovery and validation

Screenshot 2022-04-27 at 21.18.48.png

UNDERSTANDING DISEASE MECHANISMS AND DISCOVERING NEW TREATMENTS AND BIOMARKERS OF RISK FOR PATIENTS WITH MYELOID BLOOD CANCERS

Application of state-of-the-art approaches to discover new ways to detect and treat myeloid blood cancers

single_cell_trajectory_edited.jpg

CELLULAR AND MOLECULAR MEDIATORS OF BONE MARROW INFLAMMATION AND FIBROSIS

Understanding the triggers of bone marrow fibrosis (scarring) and inflammation, how this causes cancers to progress from early to advanced stage, and developing clinically-relevant systems to model this using primary human cells

Screenshot 2021-09-12 at 17.17.37.png

PLATELETS AND CANCER

Studying the utility of platelet analysis for the detection and molecular profiling of cancers.

Screenshot 2021-09-12 at 17.28.50.png
Home: Research
a8538a4773dd1b60603f6dbcfbf0b42d.jpeg

MRC WEATHERALL INSTITUTE OF MOLECULAR MEDICINE

https://www.imm.ox.ac.uk/

https://www.imm.ox.ac.uk/research/units-and-centres/mrc-molecular-haematology-unit

The MRC Weatherall Institute of Molecular Medicine (MRC WIMM) at the University of Oxford was founded in 1989 by Sir David Weatherall to foster research in molecular and cell biology, with the aim of improving human health. It houses around 400 scientists and world-class core facilities. The Molecular Haematology Unity in the MRC WIMM is focused on understanding normal and diseased blood cell production over time 

Home: About

LIFE IN OXFORD

Oxford is home to a world leading academic institution. It is a beautiful and vibrant city surrounded by incredible countryside and within easy reach from London.

ben-seymour-nqBUTBsDQNM-unsplash_edited.png
Home: About
OU_Innovation_Lab_282_by_John_Cairns_16.

GET IN TOUCH

We are always keen to hear from people who are interested in joining the group. Email: bethan.psaila@new.ox.ac.uk

Get in Touch
Home: About Me

Lab Life

The Psaila lab works closely with the Mead Lab and has strong collaborations with other groups within the Molecular Haematology Unit, Oxford and internationally. 

Our philosophy is to create a dynamic and synergistic environment that fosters and leverages the strengths of individual researchers, helping them achieve their goals while maximising our impact as a collective. We believe that this commitment to collaborative research and advocating for individuals accelerates our productivity and progress.

We enjoy regular social events, a yearly lab retreat and members of the team are all encouraged to attend relevant national/international meetings and to develop a strong research network. Group members are well supported in writing applications for independent funding and personal fellowships, and there are good opportunities for collaborations with industry.

Screenshot 2021-09-12 at 18.18.30.png
Home: Image

HUGELY GRATEFUL TO OUR FUNDERS

Please get in touch for more information about our work or if you are interested in joining us: bethan.psaila@ndcls.ox.ac.uk

Screenshot 2021-09-12 at 17.45.21.png
Home: Contact

KEY PUBLICATIONS

2023

HUMAN BONE MARROW ORGANOIDS FOR DISEASE MODELLING, DISCOVERY AND VALIDATION OF THERAPEUTIC TARGETS IN HEMATOLOGICAL MALIGNANCIES

Khan AO,  Colombo, M, Reyat JS, Wang G,  Rodriguez-Romera R,  Wen WX,  Murphy L,  Grygielska B,  Mahoney C,  Stone A,  Croft A, Bassett D,  Poologasundarampillai G,  Roy A,  Gooding S, Rayes K, Machlus KM,  Psaila B. Cancer Discovery 2023

2022

IN UTERO ORIGIN OF MYELOFIBROSIS PRESENTING IN ADULT MONOZYGOTIC TWINS AFTER A PROLONGED DISEASE LATENCY.

Sousos N, Leathlobhair MN, Simoglou Kaaral C, Louka E, Bienz N, Royston D, Clark SA, Hamblin A, Howard K, Matthews V, George B, Roy A, Psaila B, Edge DC, Mead AJ. Nature Medicine (in press)

2022

DEVELOPMENTAL STAGE- AND SITE-SPECIFIC TRANSITIONS IN LINEAGE SPECIFICATION AND GENE REGULATORY NETWORKS IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

Roy, A, Wang, G, Iskander, D, O’Byrne, S, Elliott, N, O’Sullivan, J, Buck, G, Heuston, E.F, Wen, W.X, Rodriguez Meira, A., Hua, P, Karadimitris, A, Mead A.J, Bodine, D, Roberts, I, Psaila, B* & Thongjuea, S*. * - joint senior authorship with equal contribution. Cell Reports 2021

Home: Publications

KEY PUBLICATIONS - 2021

2021

THE IMMUNE LANDSCAPE IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: INFLAMMATION, INFECTION AND OPPORTUNITIES FOR IMMUNOTHERAPY

Strickland, M., Queck L., Psaila, B*. British Journal of Haematology in press 2021

2021

IMPAIRED ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH CHRONIC MYELOID BLOOD CANCERS.

Chowdhury O, Bruguier H, Mallett G, Sousos N, Crozier K, Allman C, Eyre D, Lumley S, Strickland M, Simoglou Karali C, Murphy L, Sternberg A, Jeffery K, Mead AJ, Peniket A, Psaila B*. British Journal of Haematology 2021 Jun 16.

2021

RAPID EMERGENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA DURING JAK2 INHIBITOR THERAPY IN A PATIENT WITH MYELOFIBROSIS

Sousos N, Buch G, Rodriguez-Meira A, Norfo R, Hamblin A, Pezzella F, Davies J, Hublitz P, Psaila B, Mead AJ.
Hemasphere 2020 May 27;4(3)

Home: Publications

2020

SINGLE-CELL ANALYSES REVEAL ABERRANT PATHWAYS FOR MEGAKARYOCYTE-BIASED HEMATOPOIESIS IN MYELOFIBROSIS AND IDENTIFY MUTANT CLONE-SPECIFIC TARGETS

Psaila B*, Wang G*, Rodriguez Meira A, Li R, O’Sullivan J, Heuston E, Anderson S, Senis Y, Voegtle T, Weinberg O, Calicchio M, Milojkovic D, Roberts I, Bodine D, Thongjuea, S*, Mead AJ*.  Molecular Cell 2020 May 7th; 78:477-492

2016

SINGLE-CELL PROFILING OF HUMAN MEGAKARYOCYTE-ERYTHROID PROGENITORS IDENTIFIES DISTINCT MEGAKARYOCYTE AND ERYTHROID DIFFERENTIATION PATHWAY.

Psaila B, Barkas, N, Iskander D, Roy, A, Anderson S, Ashley, N, Caputo, V.S, Lichtenberg, J, Loaiza, S, Bodine, D, Karadimitris A, Mead A.J., Roberts I. Genome Biology Single-cell Omics Special Edition 2016 May 3; 17:83.

2012

IN VIVO EFFECTS OF ELTROMBOPAG ON PLATELET FUNCTION IN IMMUNE THROMBOCYTOPENIA: NO EVIDENCE OF PLATELET ACTIVATION.

Psaila B, Bussel JB, Linden MD, Babula B, Li Y, Barnard MR, Tate C, Mathur K, Frelinger AL, Michelson AD. Blood. 2012 Apr 26;119(17):4066-72.

Home: Publications
bottom of page